top of page


About Us   |   Team   |   Lab


Joshua Smith


20+ years leading highly innovative business with a clear vision and operational excellence.   8+ years of international regulatory experience and strategic development.

Science Team

Sally duPre, PhD

Senior Research Scientist–

40+ years in biological research and development. Specializing in immune modulators & biochemistry.


Mark Hinds

Chairman - Business Development

Executive Chairman of multiple venture funds investing in hyper innovative and disruptive businesses.  Mr. Hinds brings connections and 30+ years of business development experience to Immunacor. 

Beth McDougall

Chief Medical Officer 

20+ years of clinical practice specializing in rare viral health conditions, immunology and degenerative health.  Dr Mcdougall leads Immunacor's pioneering development strategies.  

David Franco, CFO

Chief Financial Officer

25+ years as a CPA and CFO for rapid growth companies specializing in the medical industry. 

Kim Arnott

Lab Manager

30+ years as lab director for top tier hospitals, extensive experience with regulatory compliance and lab operations.

Roland Vandemeer

Advisory Board

30+ years early venture capital experience.  Managed $2 billion+.

Kenneth Hunter, PhD

Scientific Advisor

Emeritus Professor of Immunology & Head of applied research.  Expert in Immune modulation, 60+ published papers.

bottom of page